# To Evaluate the Impact of SBI on C. Difficile in Hospitalized UC Patients

> **NCT02730325** · NA · TERMINATED · sponsor: **Northwestern University** · enrollment: 10 (actual)

## Conditions studied

- Clostridium Difficile

## Interventions

- **OTHER:** Serum-derived bovine immunoglobulin/protein isolate (SBI)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02730325
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-12
- **Primary completion:** 2017-12-12
- **Final completion:** 2018-01-05
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Study terminated due to limited enrollment.
- **Last updated:** 2021-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02730325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02730325, "To Evaluate the Impact of SBI on C. Difficile in Hospitalized UC Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02730325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*